The Consumer Product Safety Commission (CPSC) invites the public to listen in in live to the seventh meeting of the Chronic Hazard Advisory Panel (CHAP) Feb 1. as it discusses its progress toward completing its analysis of potential risks from phthalates and phthalate substitutes.

 

The CPSC appointed this CHAP on April 14, 2010, to study the effects on children’s health of all phthalates and phthalate alternatives, as used in children’s toys and child care articles, pursuant to section 108 of the Consumer Product Safety Improvement Act of 2008 (CPSIA) (Pub. L. 110–314). The CHAP will discuss its progress toward completing its analysis of potential risks from phthalates and phthalate substitutes.

 
The teleconference will take place from 11 a.m. to 1 p.m. EST (15:00 to 17:00 GMT) on Wednesday, Feb. 1, 2012. Interested members of the public may listen to the CHAP’s discussion. Members of the public will not have the opportunity to ask questions, comment, or otherwise participate in the teleconference.

 

Interested parties should contact the CPSC project manager, Michael Babich, by email (mbabich@cpsc.gov) for call-in instructions no later than Monday, January 30, 2012. An additional public meeting will be held on Wednesday, Feb. 15 through Friday, Feb. 17, 2012. The meeting will begin at approximately 9 a.m. each day. It will end at approximately 5 p.m. on Wednesday and Thursday, and at approximately 2 p.m. on Friday.

 

There will not be any opportunity for public participation at this meeting. No registration is required for the teleconference on February 1, 2012.


Please follow the instructions above regarding the call-in instructions for the teleconference. Members of the public who wish to attend the February 15–17 public meeting in person may register on the day of the meeting. This meeting will also be available live via webcast at: http://www.cpsc.gov/Webcast.

 

Registration is not necessary to view the webcast.

Further background information can be read at the Jan. 17 issue of the Federal Register.